Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
We have previously shown that a single portal vein infusion of a recombinant adeno-associated viral vector (rAAV) expressing canine Factor IX (F.IX) resulted in long-term expression of therapeutic… Expand
Safety and efficacy of gene transfer for Leber's congenital amaurosis.
- A. Maguire, F. Simonelli, +29 authors J. Bennett
- Medicine
- The New England journal of medicine
- 22 May 2008
Leber's congenital amaurosis (LCA) is a group of inherited blinding diseases with onset during childhood. One form of the disease, LCA2, is caused by mutations in the retinal pigment… Expand
Geographic distribution of the 20210 G to A prothrombin variant.
- F. Rosendaal, C. Doggen, +9 authors P. Reitsma
- Medicine
- Thrombosis and haemostasis
- 1 April 1998
A variant in prothrombin (clotting factor II), a G to A transition at nucleotide position 20210, has recently been shown to be associated with the prothrombin plasma levels and the risk of both… Expand
X-linked thrombophilia with a mutant factor IX (factor IX Padua).
- P. Simioni, D. Tormene, +7 authors V. Arruda
- Medicine
- The New England journal of medicine
- 10 December 2009
We report a case of juvenile thrombophilia associated with a substitution of leucine for arginine at position 338 (R338L) in the factor IX gene (factor IX-R338L). The level of the mutant factor IX… Expand
Hemophilia B Gene Therapy with a High‐Specific‐Activity Factor IX Variant
- L. George, S. Sullivan, +25 authors K. High
- Medicine
- The New England journal of medicine
- 6 December 2017
Background The prevention of bleeding with adequately sustained levels of clotting factor, after a single therapeutic intervention and without the need for further medical intervention, represents an… Expand
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer.
- J. Bennicelli, J. F. Wright, +17 authors J. Bennett
- Biology, Medicine
- Molecular therapy : the journal of the American…
- 1 March 2008
We evaluated the safety and efficacy of an optimized adeno-associated virus (AAV; AAV2.RPE65) in animal models of the RPE65 form of Leber congenital amaurosis (LCA). Protein expression was optimized… Expand
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
Pre-clinical studies in mice and haemophilic dogs have shown that introduction of an adeno-associated viral (AAV) vector encoding blood coagulation factor IX (F.IX) into skeletal muscle results in… Expand
Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil.
- M. S. Figueiredo, J. Kerbauy, +5 authors F. Costa
- Medicine
- American journal of hematology
- 1996
To compare the features of sickle-cell anemia in Brazil with those in other locales, we studied the effects of the beta-globin-like gene cluster haplotype and alpha-thalassemia upon the clinical and… Expand
Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease.
- V. Arruda, J. Annichino-Bizzacchi, M. S. Gonçalves, F. Costa
- Medicine, Computer Science
- Thrombosis and haemostasis
- 1 December 1997
TLDR
Prevalence of the mutation C677 --> T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil.
- V. Arruda, L. Siqueira, +5 authors F. Costa
- Biology, Medicine
- American journal of medical genetics
- 24 July 1998
Vascular disease is a serious public health problem in the industrialized world, and is a frequent cause of death among the adult population of Brazil. Mild hyperhomocysteinemia has been identified… Expand